Chromocell Therapeutics Corporation Stock
Equities
CHRO
US1711261057
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | +9.15% |
|
+14.81% | 0.00% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 9.11M 12.46M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.4% |
Latest transcript on Chromocell Therapeutics Corporation
1 day | +9.15% | ||
1 week | +14.81% | ||
Current month | +15.67% | ||
1 month | -14.84% | ||
3 months | -45.80% |
![Extreme 1.26](/images/extremecours_fleche.png)
![Extreme 1.26](/images/extremecours_fleche.png)
![Extreme 1.21](/images/extremecours_fleche.png)
![Extreme 1.21](/images/extremecours_fleche.png)
![Extreme 1.21](/images/extremecours_fleche.png)
![Extreme 1.21](/images/extremecours_fleche.png)
![Extreme 1.21](/images/extremecours_fleche.png)
![Consensus](/images/consensus_flch.gif)
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.11M | |
+15.85% | 122B | |
+18.91% | 113B | |
+4.43% | 22.84B | |
-18.63% | 20.72B | |
-13.76% | 16.39B | |
-16.61% | 16.51B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- CHRO Stock